1028 related articles for article (PubMed ID: 32467995)
21. CRISPR Diagnosis and Therapeutics with Single Base Pair Precision.
Lee SH; Park YH; Jin YB; Kim SU; Hur JK
Trends Mol Med; 2020 Mar; 26(3):337-350. PubMed ID: 31791730
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
Hashemi A
Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
[TBL] [Abstract][Full Text] [Related]
23. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
24. Application of CRISPR/Cas9 technology in sepsis research.
Wu M; Hu N; Du X; Wei J
Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568
[TBL] [Abstract][Full Text] [Related]
25. How has CRISPR transformed therapeutic drug discovery?
Parker J
Biotechniques; 2023 Mar; 74(3):119-121. PubMed ID: 37083429
[TBL] [Abstract][Full Text] [Related]
26. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
27. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
Chaterji S; Ahn EH; Kim DH
Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
[TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas9: at the cutting edge of hepatology.
Pankowicz FP; Jarrett KE; Lagor WR; Bissig KD
Gut; 2017 Jul; 66(7):1329-1340. PubMed ID: 28487442
[TBL] [Abstract][Full Text] [Related]
29. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
[TBL] [Abstract][Full Text] [Related]
30. Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing.
Tang H; Zhao X; Jiang X
Adv Drug Deliv Rev; 2021 Jan; 168():55-78. PubMed ID: 32147450
[TBL] [Abstract][Full Text] [Related]
31. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
Potts MA; McDonald JA; Sutherland KD; Herold MJ
Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
[TBL] [Abstract][Full Text] [Related]
32. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
33. Application of CRISPR genetic screens to investigate neurological diseases.
So RWL; Chung SW; Lau HHC; Watts JJ; Gaudette E; Al-Azzawi ZAM; Bishay J; Lin LT; Joung J; Wang X; Schmitt-Ulms G
Mol Neurodegener; 2019 Nov; 14(1):41. PubMed ID: 31727120
[TBL] [Abstract][Full Text] [Related]
34. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
Chakraborty C; Teoh SL; Das S
Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
[TBL] [Abstract][Full Text] [Related]
35. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
36. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
37. Exogenous gene integration mediated by genome editing technologies in zebrafish.
Morita H; Taimatsu K; Yanagi K; Kawahara A
Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
[TBL] [Abstract][Full Text] [Related]
38. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
39. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
[TBL] [Abstract][Full Text] [Related]
40. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]